Prosopis pubescens

From WikiMD's WELLNESSPEDIA

Prosopis pubescens, commonly known as the Screwbean Mesquite, is a species of flowering plant in the pea family, Fabaceae. It is native to the southwestern United States and northern Mexico, where it grows in desert and other types of dry habitats.

Description[edit]

The Prosopis pubescens is a small tree or large shrub growing up to 7 meters tall. It has a twisted trunk and a crown of spreading branches. The bark is dark brown and deeply furrowed. The leaves are bipinnate, with one or two pairs of pinnae, each pinna with several pairs of leaflets. The inflorescence is a spike of many flowers. The fruit is a legume pod, twisted into a helix, hence the common name "screwbean". The seeds are edible and were a food source for native peoples.

Distribution and habitat[edit]

The Prosopis pubescens is found in the southwestern United States, specifically in the states of California, Arizona, New Mexico, Texas, and Nevada. It also extends into northern Mexico. It is typically found in desert washes, floodplains, and other dry habitats.

Uses[edit]

The seeds of the Prosopis pubescens were traditionally used as a food source by Native American tribes, such as the Pima and Papago. The wood is also used for fuel and to make tools.

Conservation status[edit]

The Prosopis pubescens is not currently listed as threatened or endangered. However, like many desert species, it may be affected by climate change and habitat loss.

See also[edit]

References[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.